Maharashtra FDA permanently cancels Pune-based pharma firm's license over six contaminated medicines, GMP lapses
The Maharashtra FDA has permanently revoked the manufacturing license of InduCare Pharma Pvt. Ltd. following the discovery of contaminated medicines and severe manufacturing violations. Inspections revealed fungal growth, insects, and larvae in several Ayurvedic products.
The Maharashtra Food and Drug Administration (FDA) on Thursday (August 6, 2026) permanently cancelled the Ayurvedic medicine manufacturing license of Pune-based InduCare Pharma Pvt. Ltd. after six medicines failed quality tests, with some found contaminated with fungi, insects and larvae, and widespread Good Manufacturing Practice (GMP) violations.
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in